Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Show more...
FAQ
Avidity Biosciences 今天的股价是多少?▼
RNAM 当前价格为 $72.86 USD,过去 24 小时上涨了 +0.05%。在图表上更密切关注 Avidity Biosciences 股价表现。
Avidity Biosciences 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 XNAS 交易所,Avidity Biosciences 的股票以代码 RNAM 进行交易。
Avidity Biosciences 去年的营收是多少?▼
Avidity Biosciences 去年的营收为 37.51MUSD。
Avidity Biosciences 去年的净利润是多少?▼
RNAM 去年的净收益为 -1.37BUSD。
Avidity Biosciences 有多少名员工?▼
截至九月 04, 2026,公司共有511名员工。
Avidity Biosciences 属于哪个行业?▼
Avidity Biosciences从事于其他行业。
Avidity Biosciences 何时完成拆股?▼
Avidity Biosciences 最近没有进行任何拆股。
Avidity Biosciences 的总部在哪里?▼
Avidity Biosciences 的总部位于 美国 的 San Diego。